Brought to you by www.DealSearchOnline.com February 21, 2012 Issue: Recent Health Care M&A Deals Spotlight on: Pharmaceuticals Spotlight on: Managed Care Conference Calendar Recent Health Care M&A Deals Biotechnology Acquirer Target Price Biogen Idec,...
Sector Continues To Grab Biggest Share Of Market The Medical Device industry continues its domination of the health care M&A market. As noted above, this sector captured 22% of the deal volume and 40% of the dollar volume in the first month of 2012. Below we...
Prestige Brands (NYSE: PBH) is acquiring a portfolio of 17 OTC pharmaceutical brands from GlaxoSmithKline (NYSE: GSK) for $661.6 million. This acquisition, valued at 3.2x 2010 revenue, raises the buyer’s annual revenue from OTC brands to the range of $500.0 million,...
In January’s largest Biotechnology deal, Amgen, Inc. (NASDAQ: AMGN) is acquiring Micromet, Inc. (NASDAQ: MITI) for approximately $1.16 billion. Based in Rockville, Maryland, MITI discovers, develops and commercializes antibody-based therapeutics to treat cancer. On a...
Brought to you by www.DealSearchOnline.com February 13, 2012 Issue: Recent Health Care M&A Deals 2012 M&A Sprints Out Of Gate– Posts Record Deal Volume In January Spotlight on: Biotechnology Conference Calendar Recent Health Care M&A...
Posts Record Deal Volume In January January inaugurated a robust health care merger and acquisition market by posting 95 deals worth a combined total of $17.2 billion. Deal volume, in particular, reached its highest level in over a decade. This figure represents a...